Industry: Chemical & Material
Published Date: 2026-03-09
Pages: 131 Pages
Report ld: 6047119
Request Sample
Customized Report
Galacto-oligosaccharides Market Size(US$)

CAGR 2026-2032
8.7%
Market Size,2032
USD 1,732
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Galacto-oligosaccharides market is projected to grow from US$ 976 million in 2025 to US$ 1732 million by 2032, at a CAGR of 8.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Galacto-oligosaccharide (GOS) is a type of functional oligosaccharide composed mainly of galactose units with a terminal glucose residue. Naturally found in human and bovine milk, GOS serves as a prebiotic that promotes the growth of beneficial gut bacteria such as Bifidobacteria and Lactobacilli, thereby supporting digestive health and enhancing immune function. It is widely used in infant formula, dietary supplements, and functional foods.
Galacto-oligosaccharides (GOS) are recognized as functional prebiotics with established benefits in gut health improvement, immunity enhancement, and mineral absorption. As a non-digestible carbohydrate, GOS promotes the proliferation of beneficial bacteria such as bifidobacteria and lactobacilli, making it a widely adopted ingredient in infant formula, dairy products, functional beverages, and nutritional bars.
GOS products are mainly offered in two forms: Liquid and Powder. The liquid form (typically 55-70% concentration) is favored in liquid dairy, beverages, and syrups due to ease of incorporation but poses challenges in storage and transportation. The powder form, suitable for infant formula, solid beverages, nutrition bars, and baked goods, offers superior storage stability and blending flexibility, though it requires careful moisture control and may dissolve slower in certain processes. The rising trend of dietary supplements and portable functional foods has significantly boosted demand for powder GOS in recent years.
In terms of application, the Food & Beverage segment remains dominant, with widespread use in infant formula (1.5%-10%), yogurts, fermented milk, and plant-based or sports beverages. The Dietary Supplements sector is experiencing rapid growth, driven by adult prebiotic and gut-health awareness, with expanding applications in probiotic capsules, powders, and liquid supplements. Meanwhile, the Others category, such as pet food, animal feed, and skin care products, is emerging, especially in Asia's booming pet nutrition market.
Regionally, the Asia-Pacific market (China, Japan, Korea) leads in growth due to increasing health awareness and infant formula upgrades, while Europe maintains maturity through stringent regulations and product penetration. North America shows potential in functional foods and adult supplements. Intense competition exists between local Chinese players and global leaders such as FrieslandCampina, Yakult, DuPont, and Nissin.
Future trends point towards high-purity, chain-length-specific GOS, elderly and sports nutrition applications, and cost reductions via synthetic biology technologies.
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Galacto-oligosaccharides market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (capacity, sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Galacto-oligosaccharides study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue, sales, and production to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: Maps global production capacity, utilization, and market share (2021–2032), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks
Chapter 7: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 8: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 9: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 10: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 11: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth: details product specs, capacity, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 13: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles
Chapter 14: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 7-11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Galacto-oligosaccharides: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Galacto-oligosaccharides Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Liquid Form
1.2.3 Powder Form
1.3 Market Segmentation by Application
1.3.1 Global Galacto-oligosaccharides Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Food & Beverage
1.3.3 Dietary Supplements
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Galacto-oligosaccharides Revenue Estimates and Forecasts (2021-2032)
2.2 Global Galacto-oligosaccharides Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Galacto-oligosaccharides Sales Estimates and Forecasts (2021-2032)
2.4 Global Galacto-oligosaccharides Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Global Sales Market Share by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.5 Global Galacto-oligosaccharides Production Capacity and Utilization (2021 vs 2025 vs 2032)
2.6 Production Comparison by Region: 2021 vs 2025 vs 2032
3 Competitive Landscape
3.1 Global Galacto-oligosaccharides Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Galacto-oligosaccharides Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs. 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Liquid Form: Market Share by Key Manufacturers
3.5.2 Powder Form: Market Share by Key Manufacturers
3.6 Global Galacto-oligosaccharides Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Market Entry and Exit Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Galacto-oligosaccharides Sales Performance by Type
4.1.1 Global Galacto-oligosaccharides Sales Volume by Type (2021-2032)
4.1.2 Global Galacto-oligosaccharides Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Product Technology Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Galacto-oligosaccharides Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Galacto-oligosaccharides Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 Global Production Analysis
6.1 Global Galacto-oligosaccharides Production Capacity and Utilization Rates (2021–2032)
6.2 Regional Production Dynamics and Outlook
6.2.1 Historic Production by Region (2021-2026)
6.2.2 Forecasted Production by Region (2027-2032)
6.2.3 Production Market Share by Region (2021-2032)
6.2.4 Regulatory and Trade Policy Impact on Production
6.2.5 Production Capacity Enablers and Constraints
6.3 Key Regional Production Hubs
6.3.1 North America
6.3.2 Europe
6.3.3 China
6.3.4 Japan
7 North America
7.1 North America Sales Volume and Revenue (2021-2032)
7.2 North America Key Manufacturers Sales Revenue in 2025
7.3 North America Galacto-oligosaccharides Sales and Revenue by Application (2021-2032)
7.4 North America Growth Accelerators and Market Barriers
7.5 North America Galacto-oligosaccharides Market Size by Country
7.5.1 North America Revenue by Country
7.5.2 North America Sales Trends by Country
7.5.3 US
7.5.4 Canada
7.5.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2021-2032)
8.2 Europe Key Manufacturers Sales Revenue in 2025
8.3 Europe Galacto-oligosaccharides Sales and Revenue by Application (2021-2032)
8.4 Europe Growth Accelerators and Market Barriers
8.5 Europe Galacto-oligosaccharides Market Size by Country
8.5.1 Europe Revenue by Country
8.5.2 Europe Sales Trends by Country
8.5.3 Germany
8.5.4 France
8.5.5 U.K.
8.5.6 Italy
8.5.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
9.3 Asia-Pacific Galacto-oligosaccharides Sales and Revenue by Application (2021-2032)
9.4 Asia-Pacific Galacto-oligosaccharides Market Size by Region
9.4.1 Asia-Pacific Revenue by Region
9.4.2 Asia-Pacific Sales Trends by Region
9.5 Asia-Pacific Growth Accelerators and Market Barriers
9.6 Southeast Asia
9.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
9.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.7 China
9.8 Japan
9.9 South Korea
9.10 China Taiwan
9.11 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2021-2032)
10.2 Central and South America Key Manufacturers Sales Revenue in 2025
10.3 Central and South America Galacto-oligosaccharides Sales and Revenue by Application (2021-2032)
10.4 Central and South America Investment Opportunities and Key Challenges
10.5 Central and South America Galacto-oligosaccharides Market Size by Country
10.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 Brazil
10.5.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
11.3 Middle East and Africa Galacto-oligosaccharides Sales and Revenue by Application (2021-2032)
11.4 Middle East and Africa Investment Opportunities and Key Challenges
11.5 Middle East and Africa Galacto-oligosaccharides Market Size by Country
11.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
11.5.2 GCC Countries
11.5.3 Turkey
11.5.4 Egypt
11.5.5 South Africa
12 Corporate Profile
12.1 FrieslandCampina
12.1.1 FrieslandCampina Corporation Information
12.1.2 FrieslandCampina Business Overview
12.1.3 FrieslandCampina Galacto-oligosaccharides Product Models, Descriptions and Specifications
12.1.4 FrieslandCampina Galacto-oligosaccharides Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.1.5 FrieslandCampina Galacto-oligosaccharides Sales by Product in 2025
12.1.6 FrieslandCampina Galacto-oligosaccharides Sales by Application in 2025
12.1.7 FrieslandCampina Galacto-oligosaccharides Sales by Geographic Area in 2025
12.1.8 FrieslandCampina Galacto-oligosaccharides SWOT Analysis
12.1.9 FrieslandCampina Recent Developments
12.2 Yakult
12.2.1 Yakult Corporation Information
12.2.2 Yakult Business Overview
12.2.3 Yakult Galacto-oligosaccharides Product Models, Descriptions and Specifications
12.2.4 Yakult Galacto-oligosaccharides Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.2.5 Yakult Galacto-oligosaccharides Sales by Product in 2025
12.2.6 Yakult Galacto-oligosaccharides Sales by Application in 2025
12.2.7 Yakult Galacto-oligosaccharides Sales by Geographic Area in 2025
12.2.8 Yakult Galacto-oligosaccharides SWOT Analysis
12.2.9 Yakult Recent Developments
12.3 Ingredion
12.3.1 Ingredion Corporation Information
12.3.2 Ingredion Business Overview
12.3.3 Ingredion Galacto-oligosaccharides Product Models, Descriptions and Specifications
12.3.4 Ingredion Galacto-oligosaccharides Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.3.5 Ingredion Galacto-oligosaccharides Sales by Product in 2025
12.3.6 Ingredion Galacto-oligosaccharides Sales by Application in 2025
12.3.7 Ingredion Galacto-oligosaccharides Sales by Geographic Area in 2025
12.3.8 Ingredion Galacto-oligosaccharides SWOT Analysis
12.3.9 Ingredion Recent Developments
12.4 Wellneo Sugar
12.4.1 Wellneo Sugar Corporation Information
12.4.2 Wellneo Sugar Business Overview
12.4.3 Wellneo Sugar Galacto-oligosaccharides Product Models, Descriptions and Specifications
12.4.4 Wellneo Sugar Galacto-oligosaccharides Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.4.5 Wellneo Sugar Galacto-oligosaccharides Sales by Product in 2025
12.4.6 Wellneo Sugar Galacto-oligosaccharides Sales by Application in 2025
12.4.7 Wellneo Sugar Galacto-oligosaccharides Sales by Geographic Area in 2025
12.4.8 Wellneo Sugar Galacto-oligosaccharides SWOT Analysis
12.4.9 Wellneo Sugar Recent Developments
12.5 Kerry
12.5.1 Kerry Corporation Information
12.5.2 Kerry Business Overview
12.5.3 Kerry Galacto-oligosaccharides Product Models, Descriptions and Specifications
12.5.4 Kerry Galacto-oligosaccharides Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.5.5 Kerry Galacto-oligosaccharides Sales by Product in 2025
12.5.6 Kerry Galacto-oligosaccharides Sales by Application in 2025
12.5.7 Kerry Galacto-oligosaccharides Sales by Geographic Area in 2025
12.5.8 Kerry Galacto-oligosaccharides SWOT Analysis
12.5.9 Kerry Recent Developments
12.6 Quantum Hi-Tech
12.6.1 Quantum Hi-Tech Corporation Information
12.6.2 Quantum Hi-Tech Business Overview
12.6.3 Quantum Hi-Tech Galacto-oligosaccharides Product Models, Descriptions and Specifications
12.6.4 Quantum Hi-Tech Galacto-oligosaccharides Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.6.5 Quantum Hi-Tech Recent Developments
12.7 New Francisco Biotechnology
12.7.1 New Francisco Biotechnology Corporation Information
12.7.2 New Francisco Biotechnology Business Overview
12.7.3 New Francisco Biotechnology Galacto-oligosaccharides Product Models, Descriptions and Specifications
12.7.4 New Francisco Biotechnology Galacto-oligosaccharides Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.7.5 New Francisco Biotechnology Recent Developments
12.8 Baolingbao
12.8.1 Baolingbao Corporation Information
12.8.2 Baolingbao Business Overview
12.8.3 Baolingbao Galacto-oligosaccharides Product Models, Descriptions and Specifications
12.8.4 Baolingbao Galacto-oligosaccharides Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.8.5 Baolingbao Recent Developments
12.9 Shandong Bailongchuangyuan Bio-tech
12.9.1 Shandong Bailongchuangyuan Bio-tech Corporation Information
12.9.2 Shandong Bailongchuangyuan Bio-tech Business Overview
12.9.3 Shandong Bailongchuangyuan Bio-tech Galacto-oligosaccharides Product Models, Descriptions and Specifications
12.9.4 Shandong Bailongchuangyuan Bio-tech Galacto-oligosaccharides Capacity, Sales, Price, Revenue and Gross Margin (2021-2026)
12.9.5 Shandong Bailongchuangyuan Bio-tech Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Galacto-oligosaccharides Industry Chain
13.2 Galacto-oligosaccharides Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Galacto-oligosaccharides Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Galacto-oligosaccharides Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Galacto-oligosaccharides Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
14.4 Impact of U.S. Tariffs
15 Key Findings in the Global Galacto-oligosaccharides Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Galacto-oligosaccharides market size was US$ 976 million in 2025 and is forecast to reach a readjusted size of US$ 1732 million by 2032 with a CAGR of 8.7% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 79
USD 4250.00
(Single User License)
The global market for Galacto-oligosaccharides was estimated to be worth US$ 976 million in 2025 and is projected to reach US$ 1732 million, growing at a CAGR of 8.7% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 95
USD 3950.00
(Single User License)
The global Galacto-oligosaccharides market was valued at US$ 976 million in 2025 and is anticipated to reach US$ 1732 million by 2032, at a CAGR of 8.7% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 135
USD 2900.00
(Single User License)
The global Galacto-oligosaccharides market is projected to grow from US$ 874 million in 2024 to US$ 1607 million by 2031, at a CAGR of 8.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 133
USD 4900.00
(Single User License)
The global market for Galacto-oligosaccharides was estimated to be worth US$ 874 million in 2024 and is forecast to a readjusted size of US$ 1607 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published Date: 2025-06-26
Pages: 105
USD 3950.00
(Single User License)
The global Galacto-oligosaccharides market size was US$ 874 million in 2024 and is forecast to a readjusted size of US$ 1607 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published Date: 2025-06-26
Pages: 79
USD 4250.00
(Single User License)
The global market for Galacto-oligosaccharides was valued at US$ 874 million in the year 2024 and is projected to reach a revised size of US$ 1607 million by 2031, growing at a CAGR of 8.7% during the forecast period.
Published Date: 2025-06-26
Pages: 92
USD 2900.00
(Single User License)
The global Galacto-oligosaccharides market is projected to grow from US$ 976 million in 2025 to US$ 1607 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period.
Published Date: 2025-06-26
Pages: 140
USD 4900.00
(Single User License)
The global Galacto-oligosaccharides market size was US$ 976 million in 2025 and is forecast to reach a readjusted size of US$ 1732 million by 2032 with a CAGR of 8.7% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 79
The global market for Galacto-oligosaccharides was estimated to be worth US$ 976 million in 2025 and is projected to reach US$ 1732 million, growing at a CAGR of 8.7% from 2026 to 2032.
Published: 2026-03-05
Pages: 95
The global Galacto-oligosaccharides market was valued at US$ 976 million in 2025 and is anticipated to reach US$ 1732 million by 2032, at a CAGR of 8.7% from 2026 to 2032.
Published: 2026-03-05
Pages: 135
The global Galacto-oligosaccharides market is projected to grow from US$ 874 million in 2024 to US$ 1607 million by 2031, at a CAGR of 8.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 133
The global market for Galacto-oligosaccharides was estimated to be worth US$ 874 million in 2024 and is forecast to a readjusted size of US$ 1607 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published: 2025-06-26
Pages: 105
The global Galacto-oligosaccharides market size was US$ 874 million in 2024 and is forecast to a readjusted size of US$ 1607 million by 2031 with a CAGR of 8.7% during the forecast period 2025-2031.
Published: 2025-06-26
Pages: 79
The global market for Galacto-oligosaccharides was valued at US$ 874 million in the year 2024 and is projected to reach a revised size of US$ 1607 million by 2031, growing at a CAGR of 8.7% during the forecast period.
Published: 2025-06-26
Pages: 92
The global Galacto-oligosaccharides market is projected to grow from US$ 976 million in 2025 to US$ 1607 million by 2031, at a Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period.
Published: 2025-06-26
Pages: 140
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now